生物活性 | |||
---|---|---|---|
描述 | Methylene blue (Basic Blue 9) inhibits guanylyl cyclase (sGC), monoamine oxidase A (MAO-A), and NO synthase (NOS). It acts as a vasopressor and is commonly used as a medical dye. Methylene blue impacts the nitric oxide synthase/guanylate cyclase signaling pathway to modulate prepulse inhibition and is a REDOX cycling compound that can cross the blood-brain barrier. Additionally, it inhibits Tau aggregation and is known to reduce cerebral edema, attenuate microglial activation, and lessen neuroinflammation[1][2][3]. |
临床研究 | |||||
---|---|---|---|---|---|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT02380573 | Mild Cognitive Impairment ... 展开 >> MCI Aging Alzheimer's Disease AD 收起 << | Phase 2 | Active, not recruiting | July 2019 | United States, Texas ... 展开 >> Research Imaging Institute, The University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78229 收起 << |
NCT02416531 | Vulvar Lichen Sclerosus | Not Applicable | Completed | - | Brazil ... 展开 >> Hospital Pérola Byington São Paulo, SP, Brazil, 01314000 收起 << |
NCT02168452 | - | Completed | - | Korea, Republic of ... 展开 >> National Cancer Center Goyang-si, Gyeonggi-do, Korea, Republic of, 410-769 收起 << |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
3.13mL 0.63mL 0.31mL |
15.63mL 3.13mL 1.56mL |
31.26mL 6.25mL 3.13mL |
参考文献 |
---|